HYLG:NYE-Global X Funds - Global X Health Care Covered Call & Growth ETF (USD)

ETF | Others |

Last Closing

USD 25.27

Change

-0.10 (-0.37)%

Market Cap

USD 2.85M

Volume

100.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-01 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SOJE SOJE

+0.20 (+1.00%)

USD 65.72B
JEPI JPMorgan Equity Premium Income..

-0.06 (-0.11%)

USD 33.74B
DFAC Dimensional U.S. Core Equity 2..

+0.11 (+0.34%)

USD 28.49B
DTB DTB

+0.20 (+1.04%)

USD 26.58B
JPST JPMorgan Ultra-Short Income ET..

+0.02 (+0.04%)

USD 24.34B
GBTC Grayscale Bitcoin Trust (BTC)

-1.23 (-2.24%)

USD 23.75B
SGOV iShares® 0-3 Month Treasury B..

+0.03 (+0.03%)

USD 22.81B
AVUV Avantis® U.S. Small Cap Value..

N/A

USD 11.35B
JAAA Janus Detroit Street Trust - J..

+0.01 (+0.02%)

USD 10.62B
DFUV Dimensional US Marketwide Valu..

-0.05 (-0.13%)

USD 10.39B

ETFs Containing HYLG

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.96% 53% F 56% F
Dividend Return 2.00% 57% F 52% F
Total Return 4.96% 56% F 56% F
Trailing 12 Months  
Capital Gain 2.94% 44% F 48% F
Dividend Return 6.36% 86% B+ 79% B-
Total Return 9.30% 56% F 56% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 0.66% 61% D- 45% F
Dividend Return 2.63% 65% D 43% F
Total Return 1.97% 74% C 45% F
Risk Return Profile  
Volatility (Standard Deviation) 4.71% 78% C+ 91% A-
Risk Adjusted Return 55.68% 78% C+ 77% C+
Market Capitalization 2.85M 6% D- 2% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.